First Allied Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | $1.62M | Buy |
+20,305
| New | +$1.62M | 0.05% | 342 |
|
2020
Q2 | – | Sell |
-12,012
| Closed | -$755K | – | 1124 |
|
2020
Q1 | $755K | Buy |
12,012
+1,632
| +16% | +$103K | 0.03% | 472 |
|
2019
Q4 | $801K | Buy |
10,380
+1,584
| +18% | +$122K | 0.03% | 557 |
|
2019
Q3 | $641K | Sell |
8,796
-3,645
| -29% | -$266K | 0.02% | 606 |
|
2019
Q2 | $766K | Buy |
12,441
+6,360
| +105% | +$392K | 0.03% | 534 |
|
2019
Q1 | $386K | Sell |
6,081
-69
| -1% | -$4.38K | 0.01% | 759 |
|
2018
Q4 | $314K | Sell |
6,150
-192
| -3% | -$9.8K | 0.01% | 761 |
|
2018
Q3 | $365K | Buy |
+6,342
| New | +$365K | 0.01% | 826 |
|
2018
Q2 | – | Sell |
-4,503
| Closed | -$209K | – | 1171 |
|
2018
Q1 | $209K | Buy |
+4,503
| New | +$209K | 0.01% | 1022 |
|
2017
Q4 | – | Sell |
-14,253
| Closed | -$519K | – | 1536 |
|
2017
Q3 | $519K | Sell |
14,253
-5,868
| -29% | -$214K | 0.02% | 603 |
|
2017
Q2 | $798K | Sell |
20,121
-1,353
| -6% | -$53.7K | 0.04% | 482 |
|
2017
Q1 | $675K | Buy |
21,474
+1,068
| +5% | +$33.6K | 0.03% | 489 |
|
2016
Q4 | $637K | Buy |
20,406
+13,593
| +200% | +$424K | 0.03% | 511 |
|
2016
Q3 | $274K | Buy |
+6,813
| New | +$274K | 0.01% | 786 |
|
2016
Q1 | – | Sell |
-17,937
| Closed | -$472K | – | 1041 |
|
2015
Q4 | $472K | Sell |
17,937
-25,119
| -58% | -$661K | 0.02% | 600 |
|
2015
Q3 | $1.03M | Buy |
43,056
+15,102
| +54% | +$362K | 0.06% | 340 |
|
2015
Q2 | $672K | Sell |
27,954
-432
| -2% | -$10.4K | 0.03% | 511 |
|
2015
Q1 | $681K | Sell |
28,386
-4,260
| -13% | -$102K | 0.05% | 466 |
|
2014
Q4 | $694K | Buy |
32,646
+5,616
| +21% | +$119K | 0.05% | 426 |
|
2014
Q3 | $459K | Buy |
+27,030
| New | +$459K | 0.04% | 535 |
|
2014
Q2 | – | Sell |
-23,562
| Closed | -$291K | – | 1033 |
|
2014
Q1 | $291K | Buy |
23,562
+942
| +4% | +$11.6K | 0.02% | 735 |
|
2013
Q4 | $246K | Buy |
+22,620
| New | +$246K | 0.02% | 751 |
|